AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2213803 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated External Defibrillator (AED) as an adjunct to basic life support
Number of subjects: 398
Study 2213803 — intervention group
Group type: COMPARATOR
Intervention: Basic life support alone
Number of subjects: 398
Study 619237 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg exercise (bicycle)
Number of subjects: 0
Study 619237 — intervention group
Group type: COMPARATOR
Intervention: Leg injection
Number of subjects: 0
Study 619237 — intervention group
Group type: COMPARATOR
Intervention: Abdominal injection
Number of subjects: 0
Study 31494734 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transesophageal gastro-tubing (PTEG)
Number of subjects: 40
Study 31494734 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric tubing (NGT)
Number of subjects: 40
Study 30414526 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Percutaneous Kyphoplasty (MPKP)
Number of subjects: 76
Study 30414526 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Kyphoplasty (PKP)
Number of subjects: 76
Study 28858080 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose + insulin
Number of subjects: 272
Study 28858080 — intervention group
Group type: COMPARATOR
Intervention: Metformin + insulin
Number of subjects: 272
Study 25234405 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded without primer
Number of subjects: 92
Study 25234405 — intervention group
Group type: COMPARATOR
Intervention: Bonded with primer
Number of subjects: 92
Study 24120618 — intervention group
Group type: EXPERIMENTAL
Intervention: High nitrate meal (220mg of nitrate derived from spinach)
Number of subjects: 26
Study 24120618 — intervention group
Group type: COMPARATOR
Intervention: Low nitrate meal (control)
Number of subjects: 26
Study 21273182 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 74
Study 21273182 — intervention group
Group type: COMPARATOR
Intervention: Control (no darbepoetin alfa)
Number of subjects: 74
Study 19565731 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Yizhi Jiannao Granules
Number of subjects: 84
Study 19565731 — intervention group
Group type: COMPARATOR
Intervention: Yizhi Jiannao Granules
Number of subjects: 84
Study 19565731 — intervention group
Group type: COMPARATOR
Intervention: Aricept
Number of subjects: 84
Study 17026726 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia
Number of subjects: 1074
Study 17026726 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1074
Study 12651168 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical haemodynamic correction of reflux (CHIVA)
Number of subjects: 80
Study 12651168 — intervention group
Group type: COMPARATOR
Intervention: Compression treatment
Number of subjects: 80
Study 10393618 — intervention group
Group type: EXPERIMENTAL
Intervention: L-amino acid-based elemental formula (AAF)
Number of subjects: 18
Study 8763898 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornidazole
Number of subjects: 76
Study 8763898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 8763898 — intervention group
Group type: COMPARATOR
Intervention: Ornidazole and Placebo
Number of subjects: 76
Study 1909274 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 million units of Intron‐A trice weekly for 6 months (Group A)
Number of subjects: 75
Study 1909274 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose titration according to ALT-AST values (Group B)
Number of subjects: 75
Study 1909274 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone withdrawal followed by regimen A (Group C)
Number of subjects: 75
Study 1909274 — intervention group
Group type: COMPARATOR
Intervention: Control group: no treatment for 6 months (Group D)
Number of subjects: 75
Study 6636797 — intervention group
Group type: EXPERIMENTAL
Intervention: Euphyllin retard 350 mg
Number of subjects: 0
Study 6636797 — intervention group
Group type: COMPARATOR
Intervention: Mundiphyllin retard 225 mg
Number of subjects: 0
Study 6636797 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Theophylline (10 mg/kg body weight over 24 hours)
Number of subjects: 0
Study 31361726 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood salvage and reinfusion system (OrthoPat - Group 1)
Number of subjects: 70
Study 31361726 — intervention group
Group type: COMPARATOR
Intervention: Standard subfascial closed suction drain (Group 2)
Number of subjects: 70
Study 31287010 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful-compassion art therapy (MCAT)
Number of subjects: 60
Study 31287010 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control group (no immediate intervention)
Number of subjects: 60
Study 29187133 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay health advisor model intervention for organ donation education delivered by trained sorority/fraternity members over a 12-month period.
Number of subjects: 25
Study 29187133 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay health advisor model intervention for organ donation education.
Number of subjects: 25
Study 29187133 — intervention group
Group type: COMPARATOR
Intervention: Comparison group receiving education on chronic disease.
Number of subjects: 25
Study 25412293 — intervention group
Group type: EXPERIMENTAL
Intervention: Injected placebo (OxyRBX) - subcutaneous saline injections daily during the placebo phase
Number of subjects: 15
Study 25412293 — intervention group
Group type: COMPARATOR
Intervention: Control - no intervention during the control phase
Number of subjects: 15
Study 24434091 — intervention group
Group type: EXPERIMENTAL
Intervention: Bexarotene (75 mg/d)
Number of subjects: 90
Study 24434091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 21413089 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT and lime juice
Number of subjects: 120
Study 21413089 — intervention group
Group type: COMPARATOR
Intervention: ACT alone
Number of subjects: 120
Study 20015358 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytalgic (fish-oil, vitamin E, Urtica dioica)
Number of subjects: 81
Study 17014636 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive education program focused on dermatology and immunology for parents and children
Number of subjects: 61
Study 17014636 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 61
Study 17014636 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive education program
Number of subjects: 61
Study 15271195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopirox 1% shampoo applied once weekly
Number of subjects: 183
Study 15271195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopirox 1% shampoo applied twice weekly
Number of subjects: 183
Study 15271195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopirox 1% shampoo applied three times weekly
Number of subjects: 183
Study 15271195 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 183
Study 11105520 — intervention group
Group type: EXPERIMENTAL
Intervention: Short unfilled interval between exposures (< 500 msec for melodies; < 300 msec for pictures)
Number of subjects: 0
Study 11105520 — intervention group
Group type: EXPERIMENTAL
Intervention: Short unfilled interval between exposures
Number of subjects: 0
Study 9950627 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine with aura (MA) patients
Number of subjects: 81
Study 7995184 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei strain GG 10(10) colony-forming units twice daily for five days
Number of subjects: 42
Study 7995184 — intervention group
Group type: COMPARATOR
Intervention: Control group (not given lactobacilli)
Number of subjects: 42
Study 3135047 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic injection of adrenaline
Number of subjects: 68
Study 29871798 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS administered over the right parietal lobe for 10 days
Number of subjects: 36
Study 29871798 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 36
Study 28710927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful breathing
Number of subjects: 88
Study 28710927 — intervention group
Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation (LKM)
Number of subjects: 88
Study 28710927 — intervention group
Group type: COMPARATOR
Intervention: No-instruction condition
Number of subjects: 88
Study 26280691 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted Cycling Therapy (ACT)
Number of subjects: 0
Study 26280691 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary Cycling (VC)
Number of subjects: 0
Study 26280691 — intervention group
Group type: COMPARATOR
Intervention: No Cycling (NC)
Number of subjects: 0
Study 22632451 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 0
Study 22632451 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 0
Study 22632451 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0
Study 21921250 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (22,600 ppm) applied 3 times each year for 3 years
Number of subjects: 2967
Study 21921250 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 2967
Study 19178096 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular woodstick
Number of subjects: 15
Study 19178096 — intervention group
Group type: EXPERIMENTAL
Intervention: Round toothpick
Number of subjects: 15
Study 16041840 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR (100-300 mg per day for 4 weeks)
Number of subjects: 21
Study 12031879 — intervention group
Group type: EXPERIMENTAL
Intervention: HKII-positive breast cancer
Number of subjects: 100
Study 12031879 — intervention group
Group type: EXPERIMENTAL
Intervention: Glut-1-positive breast cancer
Number of subjects: 100
Study 12031879 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG uptake
Number of subjects: 100
Study 10101619 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management
Number of subjects: 14
Study 10101619 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 14
Study 7818104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (1 mg/kg)
Number of subjects: 50
Study 7818104 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (35 mg/kg)
Number of subjects: 50
Study 1693396 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice glucose polymers
Number of subjects: 16
Study 1693396 — intervention group
Group type: COMPARATOR
Intervention: Corn glucose polymers
Number of subjects: 16
Study 573007 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased serum level of TSH
Number of subjects: 0
Study 573007 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased serum level of prolactin
Number of subjects: 0
Study 573007 — intervention group
Group type: EXPERIMENTAL
Intervention: Ectopic production of peptides
Number of subjects: 0
Study 573007 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic change of peptides in elderly patients
Number of subjects: 0
Study 6345178 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (1 mg twice daily)
Number of subjects: 15
Study 6345178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6345178 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (highest tolerated dose 2-8 mg daily)
Number of subjects: 15
Study 6345178 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 15
Study 31200437 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein (HP, n = 22) - 1.2 g protein·kg‐1·d‐1
Number of subjects: 47
Study 31200437 — intervention group
Group type: COMPARATOR
Intervention: Normal protein (NP, n = 25) - 0.8 g protein·kg‐1·d‐1
Number of subjects: 47
Study 31200437 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (HP and NP)
Number of subjects: 47
Study 30045757 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication monitor-based treatment strategy
Number of subjects: 0
Study 30045757 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 26609172 — intervention group
Group type: EXPERIMENTAL
Intervention: RUSF-15%
Number of subjects: 533
Study 26609172 — intervention group
Group type: EXPERIMENTAL
Intervention: RUSF-33%
Number of subjects: 533
Study 26609172 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 533
Study 24461395 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand ibuprofen (400 mg single dose plus rescue medication)
Number of subjects: 60
Study 24461395 — intervention group
Group type: COMPARATOR
Intervention: Regular ibuprofen (400 mg every 6 hours for at least 24 hours)
Number of subjects: 60
Study 22033897 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection of hyaluronic acid (HA) and contrast dye
Number of subjects: 99
Study 22033897 — intervention group
Group type: COMPARATOR
Intervention: Blind injection of hyaluronic acid (HA) and contrast dye
Number of subjects: 99
Study 19084273 — intervention group
Group type: EXPERIMENTAL
Intervention: Travatan Dosing Aid (DA; Alcon, Fort Worth, TX)
Number of subjects: 196
Study 19084273 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report by patients
Number of subjects: 196
Study 19084273 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician assessment
Number of subjects: 196
Study 17932361 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 microg of folic acid
Number of subjects: 204
Study 17932361 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,200 microg of folic acid
Number of subjects: 204
Study 17932361 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 microg of folic acid plus 5 mg of riboflavin
Number of subjects: 204
Study 17932361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 15754276 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ascorbate (250 mg/wk, subsequently increased to 500 mg/wk)
Number of subjects: 30
Study 15754276 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ascorbate (500 mg/wk)
Number of subjects: 30
Study 15754276 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ascorbate (250 mg/wk and 500 mg/wk)
Number of subjects: 30
Study 15754276 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ascorbate (during supplementation)
Number of subjects: 30
Study 15754276 — intervention group
Group type: COMPARATOR
Intervention: Reference untreated cases
Number of subjects: 30
Study 12401606 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric lidocaine 25 mg with fentanyl 20 microg (n = 37)
Number of subjects: 72
Study 12401606 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric ropivacaine 4 mg with fentanyl 20 microg (n = 35)
Number of subjects: 72
Study 10190377 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 100 mg twice daily for 3 days
Number of subjects: 688
Study 10190377 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 200 mg twice daily for 3 days
Number of subjects: 688
Study 10190377 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole 160/800 mg twice daily for 3 days
Number of subjects: 688
Study 7549296 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypo-osmolar ORS containing L-alanine and glucose (osmolality 255 mosmol/l)
Number of subjects: 55
Study 7549296 — intervention group
Group type: COMPARATOR
Intervention: WHO-ORS (osmolality 311 mosmol/l)
Number of subjects: 55
Study 7549296 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. polyelectrolyte solutions (osmolality 293 mosmol/l)
Number of subjects: 55
Study 2184789 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet counseling
Number of subjects: 66
Study 2184789 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet counseling with exercise
Number of subjects: 66
Study 33969 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethopropazine
Number of subjects: 60
Study 33969 — intervention group
Group type: EXPERIMENTAL
Intervention: Benztropine
Number of subjects: 60
Study 33969 — intervention group
Group type: COMPARATOR
Intervention: Procyclidine
Number of subjects: 60
Study 30927373 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes (per doubling of the probability)
Number of subjects: 3541
Study 30403154 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate closure
Number of subjects: 222
Study 30403154 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation
Number of subjects: 222
Study 29845481 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tramadol 100 mg
Number of subjects: 46
Study 29845481 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ketorolac 30 mg
Number of subjects: 46
Study 27097315 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized emails encouraging application (n = 1,976)
Number of subjects: 3945
Study 27097315 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 1,969)
Number of subjects: 3945
Study 24152080 — intervention group
Group type: EXPERIMENTAL
Intervention: EmbaGYN with Kegel exercises
Number of subjects: 83
Study 22779216 — intervention group
Group type: EXPERIMENTAL
Intervention: New dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm fluoride (sodium monofluorophosphate)
Number of subjects: 0
Study 22779216 — intervention group
Group type: COMPARATOR
Intervention: Commercially available dentifrice containing 2% potassium ion (potassium nitrate)
Number of subjects: 0
Study 20540445 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure (LBPP) at 100% BW
Number of subjects: 10
Study 20540445 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure (LBPP) at 66% BW
Number of subjects: 10
Study 20540445 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure (LBPP) at 33% BW
Number of subjects: 10
Study 18236180 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly cross‐linked polyethylene (Durasul)
Number of subjects: 60
Study 18236180 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly cross‐linked polyethylene (Longevity)
Number of subjects: 60
Study 18236180 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyethylene
Number of subjects: 60
Study 18236180 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly crosslinked polyethylene
Number of subjects: 60
Study 15777304 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous PCA morphine plus ketorolac (K group)
Number of subjects: 79
Study 15777304 — intervention group
Group type: COMPARATOR
Intervention: Intravenous PCA morphine (M group)
Number of subjects: 79
Study 12007762 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine 15 mg
Number of subjects: 20
Study 12007762 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine 30 mg
Number of subjects: 20
Study 12007762 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine (15 mg or 30 mg)
Number of subjects: 20
Study 10715786 — intervention group
Group type: EXPERIMENTAL
Intervention: EVL treatment
Number of subjects: 0
Study 10715786 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 7767523 — intervention group
Group type: EXPERIMENTAL
Intervention: NPPV (noninvasive positive pressure ventilation) administered by nasal mask connected to a BiPAP device
Number of subjects: 31
Study 7767523 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy alone (control)
Number of subjects: 31
Study 2137977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin
Number of subjects: 23
Study 2137977 — intervention group
Group type: COMPARATOR
Intervention: Danazol
Number of subjects: 23
Study 10249190 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention (emotional support and information about hospitalization)
Number of subjects: 0
Study 10249190 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional support only
Number of subjects: 0
Study 31755959 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (anti-MDA5 positive)
Number of subjects: 64
Study 31755959 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (other JIIM)
Number of subjects: 64
Study 31755959 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study 31755959 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconventional treatment (more than two lines)
Number of subjects: 64
Study 29189218 — intervention group
Group type: EXPERIMENTAL
Intervention: Bryan Cervical Disc Prosthesis
Number of subjects: 70
Study 29189218 — intervention group
Group type: COMPARATOR
Intervention: ACDF
Number of subjects: 70
Study 26563657 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching ophthalmoscope
Number of subjects: 55
Study 26563657 — intervention group
Group type: COMPARATOR
Intervention: Conventional direct ophthalmoscope
Number of subjects: 55
Study 24880955 — intervention group
Group type: EXPERIMENTAL
Intervention: Beger procedure
Number of subjects: 74
Study 24880955 — intervention group
Group type: COMPARATOR
Intervention: Frey procedure
Number of subjects: 74
Study 21782401 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (800 IU)
Number of subjects: 455
Study 21782401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 455
Study 21782401 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 455
Study 19710199 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat, high-protein (HFHP) diet
Number of subjects: 10
Study 19710199 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat (HF) diet
Number of subjects: 10
Study 19710199 — intervention group
Group type: COMPARATOR
Intervention: Control isocaloric diet
Number of subjects: 10
Study 17259059 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular use of any of the three substances (alcohol, tobacco, cannabis) at age 14 or 16
Number of subjects: 1322
Study 17259059 — intervention group
Group type: COMPARATOR
Intervention: Cigarette‐only and alcohol‐only groups at age 16
Number of subjects: 1322
Study 17259059 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial factors (including attitudes to sexual risks and peer sexual norms)
Number of subjects: 1322
Study 17259059 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater intercourse frequency and pill use
Number of subjects: 1322
Study 15115249 — intervention group
Group type: COMPARATOR
Intervention: Standard clamp (insulin‐infusion rate 30 mU kg(‐1) h(‐1), glucose‐target 5.0 mmol/L)
Number of subjects: 9